MOUD and the COVID-19 National Emergency Response

The following post is from FORE’s website: https://forefdn.org/

Working with FORE, Dr. Hannah Snyder, primary care and addiction medicine specialist at Zuckerberg San Francisco General Hospital, and CA Bridge Co-PI, reviews key steps for keeping patients and providers safe while providing medications for opioid use disorder (MOUD) during the COVID-19 pandemic.

In addition, we were joined by Jodi Manz, MSW, Project Director for Chronic and Vulnerable Populations at the National Academy for State Health Policy (NASHP) and Daniel McClughen, Esq., Associate at DCBA Law & Policy, to answer questions concerning evolving regulations and newly issued guidance around MOUD during the pandemic.

We also have posted an FAQ with the most pressing questions asked on the Resources page of our website, www.ForeFdn.org.

Articles

Creating an Effective Telehealth Patient Experience for MOUD During the COVID-19 Pandemic

Leadership Approaches to Developing an Effective Drug Treatment System

Management Practices to Enhance the Effectiveness of Substance Use Disorder Treatment

Identifying relative strength of methadone versus health and social services in comprehensive substance use disorder treatment using a variance decomposition approach

A bifurcated opioid treatment system and widening insidious disparities.

Disparities in expected driving time to opioid treatment and treatment completion: findings from an exploratory study

Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017.

Using machine learning to advance disparities research: Subgroup analyses of access to opioid treatment

Gender disparities in opioid treatment progress in methadone versus counseling

Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities

Identifying gender differences in risk profiles and in opioid treatment outcomes in Los Angeles County

Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings.

A new @opioidtx study reveals the importance of Medicaid coverage, methadone, and delivery of health and social services to improve access and retention of pregnant and non-pregnant women in Los Angeles, California.

MOUD and the COVID-19 National Emergency Response

The full webinar can be accessed below.